New study tests antibodies to shield HIV-Exposed newborns
NCT ID NCT06517693
First seen Jan 25, 2026 · Last updated May 08, 2026 · Updated 13 times
Summary
This study tests whether giving special antibodies (PGT121.414.LS and VRC07-523LS) to newborns exposed to HIV is safe and how long they stay in the body. About 48 infants will receive one or two doses soon after birth. The goal is to see if these antibodies can help prevent HIV infection in babies.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV-1 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Site 31890, Harare Family Care
NOT_YET_RECRUITINGHarare, Zimbabwe
-
Site 5013, Jacobi Medical Center Bronx
NOT_YET_RECRUITINGThe Bronx, New York, 10461, United States
-
Site 5030, Emory University School of Medicine
NOT_YET_RECRUITINGAtlanta, Georgia, 30322, United States
-
Site 5051, University of Florida Jacksonville
RECRUITINGJacksonville, Florida, 32209, United States
-
Site 5052, University of Colorado Denver
RECRUITINGAurora, Colorado, 80045, United States
-
Site 5072, Hospital Federal dos Servidores do Estado
NOT_YET_RECRUITINGRio de Janeiro, CEP 20221-903, Brazil
-
Site 5083, Rush University Cook County Hospital Chicago
NOT_YET_RECRUITINGChicago, Illinois, 60612, United States
-
Site 5092, Johns Hopkins University Baltimore
RECRUITINGBaltimore, Maryland, 21287, United States
-
Site 5097, Hospital Geral De Nova Iguacu Brazil
NOT_YET_RECRUITINGRio de Janeiro, CEP 26030-380, Brazil
-
Site 5112, David Geffen School of Medicine at UCLA
NOT_YET_RECRUITINGLos Angeles, California, 90095, United States
-
Site 5114, Bronx-Lebanon Hospital Center
RECRUITINGThe Bronx, New York, 10457, United States
-
Site 5121, Kenya Medical Research Institute/Walter Reed Project Clinical Research Center, Kericho
NOT_YET_RECRUITINGKericho, 20200, Kenya
-
Site 5127, Pediatric Perinatal HIV
NOT_YET_RECRUITINGMiami, Florida, 33136, United States
-
Site 5128, Baylor College of Medicine/Texas Children's Hospital
RECRUITINGHouston, Texas, 77030, United States
-
Site 5129, IMPAACT/Gamma Project/UPR Pediatric HIV/AIDS Research
NOT_YET_RECRUITINGSan Juan, 00935, Puerto Rico
-
Site 6501, St. Jude Children's Research Hospital
NOT_YET_RECRUITINGMemphis, Tennessee, 38105, United States
-
Site 8950, FAMCRU
NOT_YET_RECRUITINGCape Town, Parrow Valley, 7505, South Africa
Conditions
Explore the condition pages connected to this study.